Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

Healthy diet and regular exercise are key to treating obesity. But the stress of everyday racism and sexism hinder Black ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...